Standard BioTools at AACR 2023: Advancing the Frontiers of Cancer Science and Medicine
The American Association for Cancer Research will be holding its annual meeting from April 14–19.
We are proud to serve a large and growing community of researchers who are making breakthroughs in translational and clinical cancer research. We appreciate your trust in Standard BioTools™ to help capture critical immune data from sample collection to novel insights with confidence ― so you don’t miss the unexpected … or even what you expect to find.
Visit Booth 1224 to discuss how you can improve your productivity and get reliable results faster. Plus, come see what we’ve got in store!
Learn and network
We are thrilled to invite you to an exciting event to socialize and network with leaders in the cancer research community.
Connect with colleagues and potential collaborators who are using high-parameter flow cytometry and Imaging Mass Cytometry™ to shape the future of clinical immunotherapies. Hear about new tools and techniques that can make a difference in how you identify cellular dynamics and spatial features.
Advancing Multiplex Spatial Analysis to New Limits
→ Speaker: Hartland Jackson, PhD
Investigator, Lunenfeld-Tanenbaum Research Institute
→ Date and time: Monday, April 17
7:00 pm | Cocktails and networking
8:00 pm | Dinner
→ Venue: The Hampton Social*
9101 International Drive, Orlando, FL 32819
* Space is limited. Please RSVP to secure your spot.
Scientific workshop on April 18 at 3:00 PM
You are invited to Unlocking the Potential of Bone Marrow imaging With Imaging Mass Cytometry to Improve Clinical Outcome Predictions in Hematologic Malignancies, an imaging workshop with Irene Ghobrial, MD, Director, Clinical Investigator Research Program, Lavine Family Chair for Preventative Cancer Therapies, Professor of Medicine, Harvard Medical School.
Tumor-immune spatial interactions have been extensively studied in solid tumors but not hematologic malignancies due to technical barriers to imaging formalin-fixed, paraffin-embedded bone marrow sections (decalcification-induced nucleic acid and protein damage, high autofluorescence). Imaging Mass Cytometry (IMC™) accurately quantifies and visualizes the bone marrow microenvironment without autofluorescence. We established a panel of 31 markers for these samples and aim to define biomarkers of clinical outcomes.
Standard BioTools is introducing its newest spatial imaging platform. Designed for clinical research, this system leverages proven IMC technology with a brand-new design and integrated workflow to translate spatial tissue context into clinical insights.
CyTOF technology
Featured in over 2,000 publications and 200 clinical trials, CyTOF® technology provides reproducible and standardized workflows, simple and easy-to-modify panel design and precise measurement of all markers. This high level of data quality empowers immune profiling for any phase of clinical research.
Microfluidics technology
Integrated into a broad range of applications, microfluidics technology accelerates genomic analysis by enabling 9,216 reactions in a single run, requiring less time, less sample and less reagent than conventional protocols. Now you can perform real-time PCR applications and NGS library prep on a single system.
SCIENTIFIC POSTERS
-
Increasing Plexity of Imaging Mass Cytometry for Tumor Tissue Analysis
-
Immuno-Oncology Study to Profile the Tumor Microenvironment in Multiple Human Cancers Using High-Plex Imaging Mass Cytometry
-
Simplifying High-Parameter Phenotypic and Functional Characterization of Immune Cells
-
50-Parameter Flow Cytometry by CyTOF Empowers Comprehensive Single-Cell Immune Profiling of Pulmonary Immunosenescence in Aged Mice
-
High-Plex Co-Detection of RNA and Protein to Explore Tumor-Immune Interactions Utilizing RNAscope™ with Imaging Mass Cytometry
-
Optimized Human Immunophenotyping Panels Enhance the Flexibility for High-Dimensional Flow Cytometry Analysis with CyTOF
-
Identifying Pathophysiological Features of Mouse Tumors Using Imaging Mass Cytometry
-
Neuro-Oncology Imaging Mass Cytometry Panels Enable Spatial Investigation of Brain Tumor Microenvironment
-
Imaging Mass Cytometry Enables Identification of Distinct Tissue Phenotypes in Highly Autofluorescent Lung and Colon Cancer Tissues, Displaying Consistent Data Across Serial Sections
Learn more about the technology
Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.